Illumina Revenue and Competitors
Estimated Revenue & Valuation
- Illumina's estimated annual revenue is currently $4.3B per year.
- Illumina's estimated revenue per employee is $384,236
- Illumina's total funding is $28M.
- Illumina's current valuation is $63.3B. (January 2022)
Employee Data
- Illumina has 11139 Employees.
- Illumina grew their employee count by -4% last year.
Illumina's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder & Chair, Impact My Shade, EMEA group for Equity, Diversity and Inclusion | Reveal Email/Phone |
2 | Engineer 2 - VP, Distinguished Engineer | Reveal Email/Phone |
3 | Administrative Partner to VP Systems Engineering & Integration | Reveal Email/Phone |
4 | Chief Global Operations | Reveal Email/Phone |
5 | Distinguished Scientist, Infectious Disease and VP at Illumina | Reveal Email/Phone |
6 | Chief Financial Officer, Chief Strategy and Corporate Development Officer | Reveal Email/Phone |
7 | CFO, Chief Strategy and Corporate Development Officer | Reveal Email/Phone |
8 | CEO | Reveal Email/Phone |
9 | Global Head & VP Medical Affairs, Illumina | Reveal Email/Phone |
10 | CEO | Reveal Email/Phone |
Illumina Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $224.5M | 891 | 38% | N/A | N/A |
#2 | $459.2M | 2508 | 5% | $242.6M | $11.6B |
#3 | $121.6M | 852 | 9% | $1.3B | $2.7B |
#4 | $7.2M | 36 | N/A | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A | N/A |
#6 | $119.4M | 659 | N/A | N/A | N/A |
#7 | $230.5M | 1240 | 52% | $338.8M | $3B |
#8 | $7.2M | 55 | N/A | N/A | N/A |
#9 | $168.6M | 860 | N/A | N/A | N/A |
#10 | $142.9M | 704 | N/A | N/A | N/A |
#11 | $950.2M | 2366 | -25% | $511.5M | N/A |
#12 | $1.5M | 17 | N/A | N/A | N/A |
#13 | $5.2M | 45 | N/A | N/A | N/A |
#14 | $5M | 32 | N/A | N/A | N/A |
#15 | $157.9M | 778 | 31% | N/A | N/A |
#16 | $281.5M | 1135 | -7% | $411.9M | $6.1B |
#17 | $4.2M | 36 | N/A | N/A | N/A |
#18 | $229.8M | 681 | N/A | N/A | N/A |
#19 | $4.3M | 37 | N/A | N/A | N/A |
#20 | $29.3M | 190 | N/A | N/A | N/A |
What Is Illumina?
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
keywords:N/A
$28M
Total Funding
11139
Number of Employees
$4.3B
Revenue (est)
-4%
Employee Growth %
$63.3B
Valuation
N/A
Accelerator
Illumina News
Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children. Hannover Medical School study will...
Illumina (ILMN 1.85%) leads the genome sequencing industry with a 90% market share in the U.S. and a 75% share globally.
Illumina (ILMN 1.85%) leads the genome sequencing industry with a 90% market share in the U.S. and a 75% share globally.
Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children. Hannover Medical School study will...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2244.6M | 11452 | -1% | N/A |
#2 | $3892.1M | 12247 | 13% | N/A |
#3 | $2551.5M | 12694 | 7% | N/A |
#4 | $5011.1M | 13257 | 7% | N/A |
#5 | $2753.9M | 13566 | 2% | N/A |